Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
KUSURI NO AOKI HOLDINGS CO.,LTD. ( (JP:3549) ) has provided an announcement.
Kusuri No Aoki Holdings has unveiled a 10-year “50th Anniversary Vision” covering fiscal 2026–2035 that targets net sales of ¥1 trillion by its 50th anniversary in 2035 and aims to rank among Japan’s top 20 retailers, following the early achievement of ¥500 billion in sales and 1,000 stores in fiscal 2025. To support this long-term ambition, the company launched a Fourth Medium-Term Management Plan for fiscal 2026–2030 built around the “Evolution of Food & Drug + Dispensing,” with goals of lifting net sales to ¥800 billion and operating profit to ¥44 billion by 2030 through strengthening fresh food offerings, expanding private-brand and dispensing businesses, and pursuing aggressive M&A to add around 400 stores, thereby reinforcing its role as local life infrastructure and responding to intensifying price competition and changing household needs.
The most recent analyst rating on (JP:3549) stock is a Hold with a Yen4228.00 price target. To see the full list of analyst forecasts on KUSURI NO AOKI HOLDINGS CO.,LTD. stock, see the JP:3549 Stock Forecast page.
More about KUSURI NO AOKI HOLDINGS CO.,LTD.
Kusuri No Aoki Holdings Co., Ltd. is a Japan-based drugstore and dispensing pharmacy operator focused on health, beauty and hygiene products, alongside an expanding food offering. With a strong regional presence and a mission to serve as essential life infrastructure in local communities, the company is increasingly positioning its stores as convenient, one-stop outlets that combine pharmaceuticals, daily necessities and fresh food, while also emphasizing capital efficiency and shareholder returns.
Average Trading Volume: 284,716
Technical Sentiment Signal: Buy
Current Market Cap: Yen349.4B
Learn more about 3549 stock on TipRanks’ Stock Analysis page.

